Suspected Peritonsillar Abscess
Patient with severe unilateral throat pain, trismus, muffled voice, fever
Peritonsillar Abscess (Quinsy) Management: Suspected Peritonsillar Abscess → Clinical Examination → Airway Compromise? → ⚠️ Airway Emergency → Initial M...
Pathway Overview
15 steps
15 total
Patient with severe unilateral throat pain, trismus, muffled voice, fever
Look for classic triad: Trismus (limited mouth opening), Uvular deviation (away from affected side), Muffled 'hot potato' voice. Also: unilateral tonsillar bulge, soft palate erythema/edema.
Signs of impending airway obstruction: stridor, drooling, inability to swallow, respiratory distress?
Call anesthesia and ENT STAT. Prepare for difficult airway. Avoid sedation. Consider awake fiberoptic intubation or surgical airway.
IV fluids for hydration. Dexamethasone 10mg IV (reduces pain and edema). IV antibiotics: Ceftriaxone 2g IV + Metronidazole 500mg IV OR Ampicillin-sulbactam 3g IV OR Clindamycin 600-900mg IV.
Both needle aspiration and incision & drainage have similar success rates. Choice depends on operator experience and patient factors.
18G needle on 10mL syringe. Topical anesthesia + local infiltration. Aspirate at point of maximal fluctuance (usually superior pole). May need multiple passes.
Was pus obtained? Did patient have symptomatic relief (reduced pain, improved mouth opening)?
Consider: phlegmon (no abscess yet), wrong location, deep space extension. Obtain CT if not already done. ENT consultation.
Obtain if: unclear diagnosis, concern for deep space extension, failed initial drainage, or immunocompromised patient.
Admit if: unable to tolerate PO, immunocompromised, concern for deep space infection, airway compromise, failed drainage, unreliable follow-up.
Oral antibiotics x 10 days: Amoxicillin-clavulanate 875/125mg BID or Clindamycin 300-450mg TID. Follow-up in 24-48 hours. Return precautions. ENT referral for tonsillectomy consideration.
Continue IV antibiotics. ENT consultation. Serial examinations. Repeat drainage if needed. Consider OR for tonsillectomy in recurrent cases.
Scalpel incision at point of maximal fluctuance. Blunt dissection with hemostats to break loculations. May be preferred for larger abscesses or failed aspiration.
Point-of-care ultrasound (POCUS): Sensitivity ~91%, specificity ~75% per 2023 meta-analysis. CT with contrast if POCUS equivocal or deep space concern. Fluctuance suggests abscess. Phlegmon = cellulitis without drainable collection.
AAFP Peritonsillar Abscess + 2024 Systematic Review
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
Applicable Regions
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
The Peritonsillar Abscess (Quinsy) Management is a emergency clinical algorithm for Otolaryngology. It provides a structured decision tree to guide clinical decision-making, based on AAFP Peritonsillar Abscess + 2024 Systematic Review.
This algorithm is based on AAFP Peritonsillar Abscess + 2024 Systematic Review (DOI: Am Fam Physician. 2008;77(2):199-202).
Known limitations include: No NICE, SIGN, or AAO-HNS formal CPG for PTA management; Steroid dosing based on limited RCT evidence; Drainage procedures require appropriate training; Deep space extension requires CT imaging; Tonsillectomy timing controversial. Individual patient factors may require deviation from these recommendations.
In AttendMe.ai, the Peritonsillar Abscess (Quinsy) Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free